The Promise and Perils of Building AI Into Your Business Applications
Paloalto Networks
AUGUST 2, 2024
Pharmaceutical enterprises are trying to use their past research, trials and outcomes to train models, thereby accelerating their ability to take their next drug to the market. But it’s not as easy as plugging an AI model into your existing infrastructure stack and calling it a win. Then, you must protect against runtime risks.
104 
Let's personalize your content